Completed NA INTERVENTIONAL 2-arm
NCT05290324
Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery
Sponsor: Chaudhry Pervaiz Elahi Institute of Cardiology
Conditions
Coronary Artery Disease
Interventions
Midazolam
Updated 3 times since 2022 Last updated: Mar 11, 2022 Started: Feb 1, 2019 Primary completion: Feb 1, 2020 Completion: Feb 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Chaudhry Pervaiz Elahi Institute of Cardiology and has accumulated 3 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Chaudhry Pervaiz Elahi Institute of Cardiology
Data source: Chaudhry Pervaiz Elahi Institute of Cardiology
For direct contact, visit the study record on ClinicalTrials.gov .